Charts FibroBiologics, Inc.

Stocks

Delayed Nasdaq 17:52:30 02/09/2026 BST			5-day change	1st Jan Change
2.015 ^USD	-4.52%		+42.89%	-55.21%

08-27	FibroBiologics, Inc. Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial	CI
08-24	Fibrobiologics, Inc. Announces Appointment of Leigh Steinberg to Board of Directors	CI

Stock exchange

Nasdaq FBLG 2.015 $ -4.52% 900K $

Markets		Price	Change	Volumes
Nasdaq	FBLG	2.015USD	-4.52%	900K $
CBOE	FBLG	1.930USD	-7.66%	19.67K $

ProRealTime Chart